Abbott Northwestern Hospital Completes First Barostim Baroreflex Activation Therapy Implant in Minnesota
Allina Health’s Abbott Northwestern Hospital achieves a major milestone with the first Barostim Baroreflex Activation Therapy implant in Minnesota. The groundbreaking procedure offers hope to heart failure patients by potentially reducing symptoms and improving quality of life. This achievement also marks a significant milestone for CVRx, as it is the company’s first Barostim implant in the United States.
Statin Therapy May Reduce Dementia Risk in Heart Failure Patients, Study Suggests
In a recent clinical study, researchers have suggested that statins could play a key role in reducing dementia in individuals with heart failure (HF). The study, published in the Lancet Regional Health, aimed to investigate the association between statin therapy…
COVID-19 Virus Found to Potentially Lead to Heart Impairment, Study Shows
SARS-CoV-2, the virus responsible for COVID-19, has been found to potentially lead to heart impairment, according to a new experimental study conducted by Japanese scientists. The study raises concerns about the impact of COVID-19 on heart health, especially for patients…